More companies join race for noninvasive glucose testing
This article was originally published in Clinica
Executive Summary
The first minimally or noninvasive glucose monitors by Cygnus and MiniMed have failed to set the market on fire, writes Shara Rosen. Neither company's product has managed to gain widespread acceptance by either physicians or patients. This leaves the race to commercialise a more consumer-friendly device wide open. Given that the worldwide market for glucose monitoring systems is estimated to reach $8.5 billion by 2005, it is not surprising that the number of contenders is growing.